1.Y.Liu, H. Zhang, Y. Liu1, S. Zhang, P. Su, L. Wang, Y. Li, Y. Liang, X. Wang, W. Zhao, B. Chen, D. Luo,N. Zhang* and Q. Yang*,Hypoxia-induced GPCPD1 depalmitoylation triggers mitophagy via regulating PRKN-mediated ubiquitination of VDAC1.Autophagy, 2023 Sep;19(9):2443-2463.
2.M. Simonetti#,N. Zhang#, L. Harbers#, M.G. Milia, S. Brossa, T.T. Huong Nguyen, F. Cerutti, E. Berrino, A. Sapino, M. Bienko, A. Sottile, V. Ghisetti and N. Crosetto,COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance.Nat Commun, 2021. 12(1): p. 3903.
3.N. Zhang, H. Zhang, Y. Liu, P. Su, J. Zhang, X. Wang, M. Sun, B. Chen, W. Zhao, L. Wang, H. Wang, M.S. Moran, B.G. Haffty and Q. Yang,SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2.Cell Death Differ, 2019. 26(5): p. 843-859.
4.H. Zhang#,N. Zhang#, Y. Liu, P. Su, Y. Liang, Y. Li, X. Wang, T. Chen, X. Song, Y. Sang, Y. Duan, J. Zhang, L. Wang, B. Chen, W. Zhao, H. Guo, Z. Liu, G. Hu and Q. Yang,Epigenetic Regulation of NAMPT by NAMPT-AS Drives Metastatic Progression in Triple-Negative Breast Cancer.Cancer Res, 2019. 79(13): p. 3347-3359.
5.Z. Fang,N. Zhang*, X. Yuan, X. Xing, X. Li, X. Qin, Z. Liu, S. Neo, C. Liu, F. Kong, M. Björkholm, Y. Fan* and D. Xu*,GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma.J Exp Clin Cancer Res, 2022. 41(1): p. 173.
6.H. Zhang#,N. Zhang#, Y. Li, Y. Liang and Q. Yang,Evaluation of efficacy of chemotherapy for mucinous carcinoma: a surveillance, epidemiology, and end results cohort study.Ther Adv Med Oncol, 2020. 12: p. 1758835920975603.
7.Y. Liu#,N. Zhang#, H. Zhang, L. Wang, Y. Duan, X. Wang, T. Chen, Y. Liang, Y. Li, X. Song, C. Li, D. Han, B. Chen, W. Zhao and Q. Yang,Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer.Drug Des Devel Ther, 2020. 14: p. 3535-3545.
8.N. Zhang, J. Zhang, H. Zhang, Y. Liu, W. Zhao, L. Wang, B. Chen, M.S. Moran, B.G. Haffty and Q. Yang,Individualized Prediction of Survival Benefit from Postmastectomy Radiotherapy for Patients with Breast Cancer with One to Three Positive Axillary Lymph Nodes.Oncologist, 2019. 24(12): p. e1286-e1293.
9.N. Zhang, X. Wang, Q. Huo, M. Sun, C. Cai, Z. Liu, G. Hu and Q. Yang,MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin.Oncogene, 2014.33(24): p. 3119-28.
10.N. Zhang, X. Wang, Q. Huo, X. Li, H. Wang, P. Schneider, G. Hu and Q. Yang,The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in breast cancer.J Biol Chem, 2013.288(13): p. 9396-407.